PharmaShots Weekly Snapshot (April 15-19, 2019)
Published: April 18, 2019 | Tags: Almac Diagnostic, Collaborates, Queens University, Personalized Chemotherapy, Esophageal Cancer
Published: April 17, 2019 | Tags: NICE, Publishes, Final Recommendation, Almirall, Ilumetri, tildrakizumab, Treat, Moderate-To-Severe, Plaque Psoriasis, Adults
Published: April 18, 2019 | Tags: Mylan, TB Alliance, Collaborates, Commercialize, Pretomanid, Two, Combination Regimens, Tuberculosis
Published: April 18, 2019 | Tags: AbbVie, Skyrizi, risankizumab, Receives, Health Canada, Approval, Moderate, Severe, Plaque Psoriasis
5.Pfizer & Eli Lilly Report Results of Tanezumab in Long-Term P-III Study for Osteoarthritis
Published: April 18, 2019 | Tags: Pfizer, Eli Lilly, Report, Results, Tanezumab, Long-Term, P-III, Study, Osteoarthritis, OA
6.World Health Organization (WHO) Reports 10 Guidelines on Digital Health Interventions
Published: April 17, 2019 | Tags: World Health Organization, WHO, Reports, 10, Guidelines, Digital Health Interventions
Published: April 17, 2019 | Tags: OncoSec, Signs, Research Agreement, Duke University School of Medicine, Evaluate, Combination, TAVO, HER2-Plasmid Vaccine
Published: April 17, 2019 | Tags: Medtronic, Reports, Results, VenaSeal Closure System, VeClose Extension Study, Chronic Venous Diseases
Published: April 17, 2019 | Tags: CASI Pharmaceutical, Signs, Exclusive, Worldwide, License, Agreement, Black Belt, TSK011010, Program
Published: April 17, 2019 | Tags: Boehringer Ingelheim, Collaborates, PureTech, Develop, Immuno-Oncology, Product, Immune Modulation
Published: April 16, 2019 | Tags: FDA, Orders, Stop, Commercialization, Surgical Mesh, Pelvic Collapse, US
Published: April 16, 2019 | Tags: Gilead, Collaborates, Insitro, Discover, Develop, Novel Therapies, Nonalcoholic Steatohepatitis, NASH, 3yrs
Published: April 16, 2019 | Tags: Thermo Fisher, Collaborates, NX Prenatal, Develop, Proteomics Assays, Adverse Pregnancy Outcomes
Published: April 16, 2019 | Tags: Novartis, Reports, Results, P-III, STR1VE Study, Zolgensma, onasemnogene abeparvovec-xioi, Spinal Muscular Atrophy, SMA, Type 1
Published: April 16, 2019 | Tags: Tessa, Collaborates, Merck, Evaluate, Combination Therapy, Metastatic, Recurrent, Cervical Cancer
Published: April 15, 2019 | Tags: Alnylam, Initiates, P-III, ILLUMINATE-B, Lumasiran, Primary Hyperoxaluria Type 1, PH1, Pediatric Patients
Published: April 15, 2019 | Tags: Janssen, Expands, Clinical Development, Guselkumab, Tremfya(R), Familial Adenomatous Polyposis, FAP
18.Eagle Restructured its Licensing Agreement with Teva for Bendeka (bendamustine hydrochloride)
Published: April 15, 2019 | Tags: Eagle, Restructured, Licensing Agreement, Teva, Bendeka, bendamustine hydrochloride
Published: April 15, 2019 | Tags: Castle Creek, Collaborates, Fibrocell, Develop, Commercialize, FCX-007, Gene Therapy, Recessive Dystrophic Epidermolysis Bullosa, RDEB
20.Novartis Reports FDAs Acceptance of BLA for Brolucizumab (RTH258) to Treat Wet AMD
Published: April 15, 2019 | Tags: Novartis, Reports, FDA, Acceptance, BLA, Brolucizumab, RTH258, Treat, Wet AMD
21.Santhera to Present Result of DELOS & SYROS Study at the 2019 MDA Clinical and Scientific Conference
Published: April 15, 2019 | Tags: Santhera; Present; Result; DELOS; SYROS; Study; 2019; Clinical; Scientific; Conference
22.Dr. Reddys to Acquire a Portfolio of 42 Abbreviated New Drug Applications (ANDA) in the US
Published: April 13, 2019 | Tags: Dr. Reddy's, Acquire, 42, Abbreviated New Drug Applications, ANDA, US
Published: April 12, 2019 | Tags: Tracon, Terminate, P-III, TAPPAS Trial, TRC105, carotuximab, Votrient, pazopanib, Advanced, Metastatic Angiosarcoma
24.Alnylam Reports Results of Givosiran in P-III ENVISION Study to Treat Acute Hepatic Porphyria
Published: April 12, 2019 | Tags: Alnylam, Reports, Results, Givosiran, P-III, ENVISION, Study, Treat Acute Hepatic Porphyria
Tags
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com